US GDP Growth Slows to 16 Signaling Weakening Economic Momentum Prediction Market Legal Battle Intensifies 16 States Taking Action Against Platforms One Moves to Ban Bata India Targets 3000 Stores Accelerates Digital Commerce and Premiumisation Push Bajaj Finance Trading Update Market Participants Monitor Stock Activity Global Leaders Watch Closely as TrumpXi Summit Approaches From Singapore to Brussels New Fed Chair Kevin Warsh Faces Potential Headwinds Amid Trumps Policy Legacy PHAR Q1 2026 Earnings EPS Misses Expectations by Wide Margin Stock Declines ARM Q1 2026 Earnings EPS Beat Amidst Revenue Discrepancy Uncertainty Banco De Chile ADS BCH Q4 2025 Earnings EPS Miss Weighs on Shares Despite Steady Operational Performance Sachem Capital Corp 600 Notes due 2027 SCCE Q4 2025 Earnings Massive EPS Surprise Highlights Resilient Operating Performance Constellium SE CSTM Q1 2026 Earnings EPS Soars 128 Above Consensus Stock Rises Currenc Group Inc CURR Q3 2025 Earnings EPS Surges Past Estimates Yet Shares Slide Hawkins Inc HWKN Posts Solid Gains Approaching Key Resistance Amid Strong Momentum Axe Compute Inc AGPU Gains 168 as Stock Tests Key Resistance Zone Midland States Bancorp Inc MSBI Edges Higher Amid Steady Trading BGSF Inc BGSF Slides 323 as Selling Pressure Intensifies Below Resistance Nauticus Robotics Warrants KITTW Hold Near Penny Levels as Trading Remains Sluggish Fragmented HR Systems May Be Costing US Companies Millions in Payroll Errors FSEA Q3 2024 Earnings Modest Profitability Amidst Stable Operations Propanc Biopharma PPCB Slides 69 as Weak Momentum Tests Key Support Beyond Air Inc XAIR Gains Over 6 as Stock Tests Key Resistance at 048 FG Stock Holds Near Support Amid Quiet Trading Session Plum Acquisition Corp IV PLMK Holds Steady at 1063 A SPAC in WaitandSee Mode Winchester Bancorp WSBK Posts Slight Decline Holds Steady Above Key Support Level NewAmsterdam Pharma NAMS Slightly Lower Amid Consolidation Near Key Support Levels Global Industrial Company GIC Advances 22 Testing Key Resistance Zone Intellia Therapeutics Slides Slightly Amid Cautious Trading in GeneEditing Sector